MedPath

Effects of gene expression pattern and RAS/BRAF mutations on the course of colorectal cancer

Not Applicable
Recruiting
Conditions
Colorectal cancer
Cancer
Registration Number
ISRCTN18093312
Lead Sponsor
FGBU State scientific centre of coloproctology Ministry of Health of Russia
Brief Summary

2017 results in: https://doi.org/10.1134/S1022795418060091

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Potentially curable colorectal cancer

Exclusion Criteria

1. Participants that have had preoperative chemotherapy and/or radiotherapy
2. Patient that refuse to follow the study protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease-free survival (DFS)
Secondary Outcome Measures
NameTimeMethod
<br> 1. Overall survival (OS)<br> 2. Time to relapse (TTR)<br>
© Copyright 2025. All Rights Reserved by MedPath